Light-controlled inhibition of the circadian regulator RORγ

31 July 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Retinoic acid receptor-related orphan receptor γ (RORγ) is a circadian regulator and has emerged as experimental therapeutic target in inflammation and immunity. The cyclic temporal role of RORγ in circadian rhythms makes temporally-resolved pharmacological control of this receptor particularly intriguing. To achieve next-generation tools to study RORγ biology, we designed RORγ ligands featuring a central azobenzene photoswitch, that act as light-dependent inverse agonists. Structural optimization enabled efficient photocontrol over RORγ inhibition, with remarkable potency on RORγ and excellent selectivity over related receptors. These high-specificity photopharmaceuticals can serve as high-precision tools to study the dynamic modulation of RORγ in signaling pathways and in inflammatory disorders.

Keywords

Photopharmacology
nuclear hormone receptors
transcription factor
photoswitch
azobenzene
photochromism
optogenetics
molecular switch
molecular machine
RAR-related orphan receptor gamma
RORγ
photoresponsive probe
photopharmaceutical
photochemistry
photopharmacological tool compounds
Optical Control
optogenetics tools
photocontrol
photochromic compounds
light-control
photoswitchable activity
circadian rhythm
inflammation
Th17 cells
RORγt
autoimmune diseases
t-cell differentiation
psoriasis

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Synthesis and Methods
Actions

Supplementary weblinks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.